Page last updated: 2024-12-10

bigelovin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bigelovin: a potent cytotoxic sesquiterpene lactone from Inula sp.; structure given in first source; RN refers to (3aR-(3aalpha,4alpha,4abeta,7aalpha,8alpha,9abeta))-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

bigelovin : A sesquiterpene lactone that is 3,3a,4,4a,7a,8,9,9a-octahydroazuleno[6,5-b]furan-2,5-dione substituted by methyl groups at positions 4a and 8, a methylidene group at position 3 and an acetoxy group at position 4. Isolated from Inula hupehensis, it exhibits antineoplastic activity. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
InulagenusA plant genus of the family ASTERACEAE. Members contain INULIN, alantol, helenin, alantic acid, and acrid resin.[MeSH]AsteraceaeA large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of daisy refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.[MeSH]
Inula hupehensisspecies[no description available]AsteraceaeA large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of daisy refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.[MeSH]

Cross-References

ID SourceID
PubMed CID3080597
CHEMBL ID486997
CHEBI ID69337
MeSH IDM0261869

Synonyms (17)

Synonym
ambrosa-2,11(13)-dien-12-oic acid, 6alpha,8alpha-dihydroxy-4-oxo-, 12,8-lactone, acetate
3668-14-2
CHEMBL486997
6-o-acetylmexicanin
chebi:69337 ,
bigelovin
[(3as,5r,5ar,8ar,9s,9ar)-5,8a-dimethyl-1-methylidene-2,8-dioxo-3a,4,5,5a,9,9a-hexahydroazuleno[6,5-b]furan-9-yl] acetate
(3ar,4s,4ar,7ar,8r,9as)-4a,8-dimethyl-3-methylidene-2,5-dioxo-2,3,3a,4,4a,5,7a,8,9,9a-decahydroazuleno[6,5-b]furan-4-yl acetate
6alpha,8alpha-dihydroxy-4-oxo-ambrosa-2,11(13)-dien-12-oic acid-12,8-lactone acetate
3OZJ
DTXSID80190130
CS-0065662
HY-116506
Q27137678
F82266
MS-24395
AKOS040763664

Research Excerpts

Overview

Bigelovin is a sesquiterpene lactone isolated from the plant Inula helianthus-aquatica. It has been reported to induce apoptosis and show anti-inflammatory and anti-angiogenic activities.

ExcerptReferenceRelevance
"Bigelovin is a sesquiterpene lactone isolated from the plant Inula helianthus-aquatica which was traditionally used in cancer treatment in Yunnan, China. "( Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica.
Chan, BC; Fung, KP; Ji, CJ; Kwok, HF; Lau, CB; Leung, HW; Leung, PC; Tan, NH; Wong, YL; Yue, GG, 2013
)
2.06
"Bigelovin (BigV) is a sesquiterpene lactone, isolated from Inula helianthus aquatica, which has been reported to induce apoptosis and show anti-inflammatory and anti-angiogenic activities. "( Bigelovin, a sesquiterpene lactone, suppresses tumor growth through inducing apoptosis and autophagy via the inhibition of mTOR pathway regulated by ROS generation in liver cancer.
Nie, CH; Wan, DL; Wang, B; Zheng, SS; Zhou, TY, 2018
)
3.37

Toxicity

ExcerptReferenceRelevance
" Within a series of helenalin esters, the acetate (2) and isobutyrate (3) were more toxic than helenalin itself (1)."( Structure-cytotoxicity relationships of some helenanolide-type sesquiterpene lactones.
Beekman, AC; Konings, AW; Pras, N; Schmidt, TJ; van Uden, W; Wikström, HV; Woerdenbag, HJ, 1997
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
apoptosis inducerAny substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
immunomodulatorBiologically active substance whose activity affects or plays a role in the functioning of the immune system.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (5)

ClassDescription
acetate esterAny carboxylic ester where the carboxylic acid component is acetic acid.
organic heterotricyclic compoundAn organic tricyclic compound in which at least one of the rings of the tricyclic skeleton contains one or more heteroatoms.
sesquiterpene lactoneAny member of a diverse class of complex, multicyclic phytochemicals showing a variety of skeleton arrangements and bioactivities, and having in common a sesquiterpenoid structure including a lactone ring.
cyclic ketone
gamma-lactoneA lactone having a five-membered lactone ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Retinoic acid receptor RXR-alphaHomo sapiens (human)ED504.90004.90004.90004.9000AID1180602
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (16)

Processvia Protein(s)Taxonomy
positive regulation of cholesterol effluxRetinoic acid receptor RXR-alphaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIRetinoic acid receptor RXR-alphaHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIRetinoic acid receptor RXR-alphaHomo sapiens (human)
positive regulation of thyroid hormone mediated signaling pathwayRetinoic acid receptor RXR-alphaHomo sapiens (human)
hormone-mediated signaling pathwayRetinoic acid receptor RXR-alphaHomo sapiens (human)
positive regulation of bone mineralizationRetinoic acid receptor RXR-alphaHomo sapiens (human)
positive regulation of transporter activityRetinoic acid receptor RXR-alphaHomo sapiens (human)
response to retinoic acidRetinoic acid receptor RXR-alphaHomo sapiens (human)
peroxisome proliferator activated receptor signaling pathwayRetinoic acid receptor RXR-alphaHomo sapiens (human)
mRNA transcription by RNA polymerase IIRetinoic acid receptor RXR-alphaHomo sapiens (human)
steroid hormone mediated signaling pathwayRetinoic acid receptor RXR-alphaHomo sapiens (human)
positive regulation of DNA-templated transcriptionRetinoic acid receptor RXR-alphaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIRetinoic acid receptor RXR-alphaHomo sapiens (human)
retinoic acid receptor signaling pathwayRetinoic acid receptor RXR-alphaHomo sapiens (human)
positive regulation of vitamin D receptor signaling pathwayRetinoic acid receptor RXR-alphaHomo sapiens (human)
cell differentiationRetinoic acid receptor RXR-alphaHomo sapiens (human)
anatomical structure developmentRetinoic acid receptor RXR-alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (22)

Processvia Protein(s)Taxonomy
vitamin D response element bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
transcription cis-regulatory region bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
RNA polymerase II transcription regulatory region sequence-specific DNA bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificRetinoic acid receptor RXR-alphaHomo sapiens (human)
transcription coregulator bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
retinoic acid bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
double-stranded DNA bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
DNA-binding transcription factor activityRetinoic acid receptor RXR-alphaHomo sapiens (human)
nuclear steroid receptor activityRetinoic acid receptor RXR-alphaHomo sapiens (human)
nuclear receptor activityRetinoic acid receptor RXR-alphaHomo sapiens (human)
protein bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
zinc ion bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
enzyme bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
peptide bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
identical protein bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
nuclear vitamin D receptor bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
sequence-specific DNA bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
retinoic acid-responsive element bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
DNA binding domain bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
LBD domain bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
sequence-specific double-stranded DNA bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (8)

Processvia Protein(s)Taxonomy
nucleusRetinoic acid receptor RXR-alphaHomo sapiens (human)
nucleoplasmRetinoic acid receptor RXR-alphaHomo sapiens (human)
transcription regulator complexRetinoic acid receptor RXR-alphaHomo sapiens (human)
mitochondrionRetinoic acid receptor RXR-alphaHomo sapiens (human)
cytosolRetinoic acid receptor RXR-alphaHomo sapiens (human)
RNA polymerase II transcription regulator complexRetinoic acid receptor RXR-alphaHomo sapiens (human)
chromatinRetinoic acid receptor RXR-alphaHomo sapiens (human)
receptor complexRetinoic acid receptor RXR-alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (37)

Assay IDTitleYearJournalArticle
AID725132Immunomodulatory effect in phytohemagglutininin-activated human PBMC assessed as inhibition of INFgamma production measured after 24 hrs by ELISA2013European journal of medicinal chemistry, Jan, Volume: 59Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica.
AID725138Inhibition of HMEC1 cells growth measured after 48 hrs by MTT assay2013European journal of medicinal chemistry, Jan, Volume: 59Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica.
AID725129Immunomodulatory effect in phytohemagglutininin-activated human PBMC assessed as inhibition of INFgamma production at 250 nM measured after 24 hrs by ELISA2013European journal of medicinal chemistry, Jan, Volume: 59Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica.
AID1180602Agonist activity at human RXR-alpha expressed in HEK293 cells coexpressing with pCMX-beta-gal after 24 to 48 hrs by luciferase reporter gene assay2014Journal of natural products, Jul-25, Volume: 77, Issue:7
Rexinoids isolated from Sophora tonkinensis with a gene expression profile distinct from the synthetic rexinoid bexarotene.
AID725142Anti-angiogenic activity in transgenic zebrafish Tg(fli1a:EGFP)y1 1 to 4 cell stage embryo assessed as down-regulation of Tie-2 angiogenic gene expression measured after 24 hrs by real-time PCR analysis2013European journal of medicinal chemistry, Jan, Volume: 59Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica.
AID725131Immunomodulatory effect in phytohemagglutininin-activated human PBMC assessed as inhibition of IL2 production measured after 24 hrs by ELISA2013European journal of medicinal chemistry, Jan, Volume: 59Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica.
AID725123Effect on cell adhesion gene expression in TNFalpha stimulated HMEC1 cells assessed as reduction in VCAM1 mRNA level at 1000 or 3000 nM measured after 12 hrs by real-time PCR analysis2013European journal of medicinal chemistry, Jan, Volume: 59Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica.
AID725135Immunomodulatory effect in phytohemagglutininin-activated human PBMC assessed as stimulation of cell proliferation at 62.5 to 250 nM measured after 72 hrs2013European journal of medicinal chemistry, Jan, Volume: 59Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica.
AID725128Immunomodulatory effect in phytohemagglutininin-activated human PBMC assessed as inhibition of TNFalpha production at 250 nM measured after 24 hrs by ELISA2013European journal of medicinal chemistry, Jan, Volume: 59Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica.
AID401842Cytotoxicity against mouse cloned EN2 cells after 2 hrs by MTT assay1997Journal of natural products, Mar, Volume: 60, Issue:3
Structure-cytotoxicity relationships of some helenanolide-type sesquiterpene lactones.
AID725141Anti-angiogenic activity in transgenic zebrafish Tg(fli1a:EGFP)y1 1 to 4 cell stage embryo assessed as down-regulation of Ang-1 angiogenic gene expression measured after 24 hrs by real-time PCR analysis2013European journal of medicinal chemistry, Jan, Volume: 59Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica.
AID725124Cytotoxicity against human HMEC1 cells2013European journal of medicinal chemistry, Jan, Volume: 59Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica.
AID725146Anti-angiogenic activity in transgenic zebrafish Tg(fli1a:EGFP)y1 1 to 4 cell stage embryo assessed as inhibition of subintestinal vessels formation measured after 48 hrs by fluorescent microscopy2013European journal of medicinal chemistry, Jan, Volume: 59Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica.
AID725119Effect on cell adhesion gene expression in TNFalpha stimulated HMEC1 cells assessed as reduction in VCAM1 protern expression at 1000 or 3000 nM measured after 24 hrs by Western blotting2013European journal of medicinal chemistry, Jan, Volume: 59Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica.
AID725139Inhibition of cell proliferation of HMEC1 cells assessed as [methyl-3H] thymidine incorporation measured after 48 hrs2013European journal of medicinal chemistry, Jan, Volume: 59Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica.
AID725125Effect on cell adhesion gene expression in TNFalpha stimulated HMEC1 cells assessed as reduction in ICAM1 mRNA level at 1000 or 3000 nM measured after 12 hrs by real-time PCR analysis2013European journal of medicinal chemistry, Jan, Volume: 59Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica.
AID725144Anti-angiogenic activity in transgenic zebrafish Tg(fli1a:EGFP)y1 1 to 4 cell stage embryo assessed as inhibition of subintestinal vessel length measured at 25 to 100 uM after 48 hrs by fluorescent microscopy2013European journal of medicinal chemistry, Jan, Volume: 59Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica.
AID725127Immunomodulatory effect in phytohemagglutininin-activated human PBMC assessed as inhibition of IL2 production at 250 nM measured after 24 hrs by ELISA2013European journal of medicinal chemistry, Jan, Volume: 59Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica.
AID626782Antiinflammatory action in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production treated 30 mins before LPS challenge measured after 24 hrs by griess reaction2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Pseudoguaianolides and guaianolides from Inula hupehensis as potential anti-inflammatory agents.
AID771667Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 72 hrs by MTT assay2013European journal of medicinal chemistry, Oct, Volume: 68Selective cytotoxicity, inhibition of cell cycle progression, and induction of apoptosis in human breast cancer cells by sesquiterpenoids from Inula lineariifolia Turcz.
AID725130Immunomodulatory effect in phytohemagglutininin-activated human PBMC assessed as inhibition of IL12 production measured after 24 hrs by ELISA2013European journal of medicinal chemistry, Jan, Volume: 59Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica.
AID725121Cytotoxicity against human HMEC1 cells at 1000 or 3000 nM measured after 12 hrs by MTT assay2013European journal of medicinal chemistry, Jan, Volume: 59Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica.
AID725126Inhibition of adhesion of THP1 cells to TNFalpha stimulated HMEC1 cells measured after 5 hrs2013European journal of medicinal chemistry, Jan, Volume: 59Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica.
AID725140Anti-angiogenic activity in transgenic zebrafish Tg(fli1a:EGFP)y1 1 to 4 cell stage embryo assessed as down-regulation of Tie-1 angiogenic gene expression measured after 24 hrs by real-time PCR analysis2013European journal of medicinal chemistry, Jan, Volume: 59Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica.
AID725145Anti-angiogenic activity in transgenic zebrafish Tg(fli1a:EGFP)y1 1 to 4 cell stage embryo assessed as complete inhibition of subintestinal vessels formation measured at 100 uM after 48 hrs by fluorescent microscopy2013European journal of medicinal chemistry, Jan, Volume: 59Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica.
AID725143Anti-angiogenic activity in transgenic zebrafish Tg(fli1a:EGFP)y1 1 to 4 cell stage embryo assessed as down-regulation of Ang-2 angiogenic gene expression measured after 24 hrs by real-time PCR analysis2013European journal of medicinal chemistry, Jan, Volume: 59Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica.
AID771666Cytotoxicity against human MCF10A cells assessed as growth inhibition after 72 hrs by MTT assay2013European journal of medicinal chemistry, Oct, Volume: 68Selective cytotoxicity, inhibition of cell cycle progression, and induction of apoptosis in human breast cancer cells by sesquiterpenoids from Inula lineariifolia Turcz.
AID725137Inhibition of HMEC1 cells growth measured after 48 hrs2013European journal of medicinal chemistry, Jan, Volume: 59Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica.
AID725120Effect on cell adhesion gene expression in TNFalpha stimulated HMEC1 cells assessed as reduction in E-selectin protern expression at 1000 or 3000 nM measured after 24 hrs by Western blotting2013European journal of medicinal chemistry, Jan, Volume: 59Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica.
AID725122Effect on cell adhesion gene expression in TNFalpha stimulated HMEC1 cells assessed as reduction in E-selectin mRNA level at 1000 or 3000 nM measured after 12 hrs by real-time PCR analysis2013European journal of medicinal chemistry, Jan, Volume: 59Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica.
AID725134Immunomodulatory effect in phytohemagglutininin-activated human PBMC assessed as inhibition of TNFalpha production measured after 24 hrs by ELISA2013European journal of medicinal chemistry, Jan, Volume: 59Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica.
AID725136Antimigratory activity against HMEC1 cells assessed as decrease in cell motility measured after 24 hrs by scratch wound assay2013European journal of medicinal chemistry, Jan, Volume: 59Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica.
AID725133Cytotoxicity against human PBMC at 62.5 to 250 nM for 72 hrs by XTT assay2013European journal of medicinal chemistry, Jan, Volume: 59Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica.
AID401843Cytotoxicity against mouse cloned EN2 cells after 72 hrs by MTT assay1997Journal of natural products, Mar, Volume: 60, Issue:3
Structure-cytotoxicity relationships of some helenanolide-type sesquiterpene lactones.
AID771668Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay2013European journal of medicinal chemistry, Oct, Volume: 68Selective cytotoxicity, inhibition of cell cycle progression, and induction of apoptosis in human breast cancer cells by sesquiterpenoids from Inula lineariifolia Turcz.
AID725118Effect on cell adhesion gene expression in TNFalpha stimulated HMEC1 cells assessed as reduction in ICAM1 protern expression at 1000 or 3000 nM measured after 24 hrs by Western blotting2013European journal of medicinal chemistry, Jan, Volume: 59Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica.
AID626783Cytotoxicity against mouse RAW264.7 cells after 24 hrs by MTT assay2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Pseudoguaianolides and guaianolides from Inula hupehensis as potential anti-inflammatory agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (11.76)18.2507
2000's2 (11.76)29.6817
2010's11 (64.71)24.3611
2020's2 (11.76)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.41 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index5.30 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]